JPDA announces measures to tackle unethical practices in pharmaceutical trade – Jammu Kashmir Latest News | Tourism

JPDA Chairman Rakesh Gupta during a press conference in Jammu.

Excelsior Correspondent
JAMMU, 13th March: The Jammu Pharmaceutical Distributors Association (JPDA) today announced strong and effective measures to counter ‘unethical tactics’ and ‘selection tactics’ adopted and launched by multi-brand companies in the noble pharmaceutical business, paving the way for “fake and substandard drugs to enter the market.”
Addressing a press conference here today, JPDA Chairman Rakesh Gupta said the ‘price war’ which has been unleashed by multi-brand companies in Jammu and Kashmir and across the India has led to unhealthy and unethical lure practices of offering huge discounts in the drug trade. He added that our trade is governed by the Medicines Price Control Ordinance which clearly defines profit margins at wholesale and retail level.

Click here to watch the video
Gupta said that after complete silence and inaction from the National Pharmaceutical Pricing Authority and the Competition Commission of India, even after sensational revelations made by their association in the recent past, they are obliged to take strict and rigorous measures in the interest of health care. .
He announced a series of measures to be implemented on a war footing, including strict implementation of the practice of importing drugs only through manufacturers’ authorized channels, discouraging and not cooperating with anyone who adopted seduction tactics by posting discount offers, complete non-cooperation to anyone importing drugs from unauthorized channels to achieve high profit margins beyond what was defined in the Ordinance on control of drug prices.
Gupta urged pharmaceutical manufacturers to implement and by all means stop and discourage inter and intra-regional infiltration of drugs through unauthorized channels and end the practice of “special discounted tariffs”. for everyone. He added that various internal measures are also taken to regulate the drug trade in the broader interest of patient care and as a moral obligation.
Other JPDA officers present at the press conference were Ajay Gupta (Senior Vice President), Brijesh Gupta (Vice President), Rajan Gupta (General Secretary), Ravinder Gandaral (Secretary) and Manmeet Singh (Treasurer). .

Previous postMHA to review situation at J&K after attacks on Panchayat members and others
Next postShiv Nirmohi releases “Dhaarey Da Shallaipa” by Mohan Lal Pant

The main daily newspaper in Jammu and Kashmir, India


About Author

Comments are closed.